Extend Biosciences Inc. SBIR Phase I Award, March 2020
A SBIR Phase I contract was awarded to Extend Biosciences in March, 2020 for $161,589.0 USD from the U.S. Department of Defense and Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense.
Currently, there are no issues on this topic.
Find more entities like Extend Biosciences Inc. SBIR Phase I Award, March 2020
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
